Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -21.83%-360.06K | 13.77%-212.9K | 6.59%-620.1K | -3.24%-1.56M | 22.24%-356.71K | -3.81%-295.53K | 38.65%-246.89K | -80.34%-663.84K | 61.41%-1.51M | 51.83%-458.71K |
| Net income from continuing operations | -18.05%-719.24K | 39.06%-444.54K | -116.78%-1.19M | 11.11%-2.84M | 3.36%-951.09K | -9.73%-609.26K | 9.60%-729.43K | 35.25%-547.91K | 56.76%-3.19M | 22.30%-984.11K |
| Operating gains losses | 498.28%53.68K | -184.55%-69.08K | -258.01%-46.64K | 774.62%130.89K | 150.87%53.25K | 306.44%8.97K | --81.7K | -580.97%-13.03K | 381.04%14.97K | 393.35%21.22K |
| Depreciation and amortization | 2.39%80.41K | 15.99%80.15K | 12.34%80.93K | 7.78%298.2K | -33.97%78.52K | 31.54%78.54K | 40.75%69.1K | 47.13%72.04K | 95.22%276.69K | 249.91%118.92K |
| Asset impairment expenditure | ---- | ---- | ---- | 35.55%93.53K | ---- | ---- | ---- | ---- | --69K | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Remuneration paid in stock | --0 | --0 | 801.85%153.85K | 2,179.45%114.45K | 1,839.69%97.39K | --0 | --0 | --17.06K | -97.23%5.02K | --5.02K |
| Deferred tax | -49.03%2.07K | -49.09%2.08K | --2.15K | 331.59%8.22K | 102.48%88 | --4.06K | --4.08K | --0 | ---3.55K | ---3.55K |
| Other non cashItems | 154.38%188.23K | -2.18%-72.36K | 149.06%139.42K | 2,436.33%186.63K | 290.94%127.47K | 232.89%74K | -223.74%-70.81K | -2.18%55.98K | -100.30%-7.99K | -232.39%-66.76K |
| Change In working capital | -76.52%34.8K | -27.01%290.85K | 195.97%237.98K | -66.57%442.81K | -62.22%144.14K | -45.30%148.18K | 33.64%398.47K | -166.33%-247.98K | 252.77%1.32M | 69.07%381.54K |
| -Change in receivables | -1,096.78%-263.25K | -11,437.98%-52.84K | 47.09%45.74K | -219.61%-119.74K | ---177.71K | --26.41K | --466 | --31.1K | 22,054.61%100.11K | ---- |
| -Change in prepaid assets | -1,824.38%-57K | -174.71%-38.16K | 126.45%28.07K | -143.05%-42.71K | --15.33K | ---2.96K | --51.08K | ---106.15K | 63.34%-17.57K | ---- |
| -Change in payables and accrued expense | 184.65%355.05K | 10.07%381.85K | 194.93%164.17K | -51.26%605.26K | --306.53K | --124.73K | --346.93K | ---172.93K | 184.78%1.24M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -21.83%-360.06K | 13.77%-212.9K | 6.59%-620.1K | -3.24%-1.56M | 22.24%-356.71K | -3.81%-295.53K | 38.65%-246.89K | -80.34%-663.84K | 61.41%-1.51M | 51.83%-458.71K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 196.11%47.89K | -119.13%-17.17K | 90.94%-11.19K | -136.38%-87.47K | -106.67%-3.86K | -194.17%-49.83K | -66.94%89.75K | 12.94%-123.53K | 114.66%240.44K | 106.85%57.92K |
| Net PPE purchase and sale | 89.76%-4.95K | --0 | 89.45%-12.51K | 34.13%-80.13K | -105.16%-3.42K | ---48.3K | --90.2K | 36.92%-118.61K | 84.25%-121.66K | 2,215.33%66.38K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other investing changes | 3,548.56%52.83K | -3,707.32%-17.17K | 126.90%1.32K | -102.03%-7.34K | 94.81%-439 | -102.90%-1.53K | -100.17%-451 | -110.65%-4.91K | 173.57%362.1K | -105.36%-8.46K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 196.11%47.89K | -119.13%-17.17K | 90.94%-11.19K | -136.38%-87.47K | -106.67%-3.86K | -194.17%-49.83K | -66.94%89.75K | 12.94%-123.53K | 114.66%240.44K | 106.85%57.92K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 241.10%775.55K | -27.05%165.38K | -72.61%226.54K | 53.07%2.09M | 97.05%805.11K | -27.48%227.37K | 110.52%226.72K | 55.13%827.11K | -75.47%1.36M | -75.65%408.59K |
| Net issuance payments of debt | 15,333.31%243.28K | -320.18%-45.53K | -179.55%-33.95K | -198.80%-154.89K | -297.81%-216.65K | -101.45%-1.6K | -80.80%20.68K | 710.70%42.68K | -86.07%156.76K | -104.46%-54.46K |
| Net common stock issuance | --461.98K | --0 | --0 | 40.95%1.77M | 84.83%923.92K | --0 | --0 | 52.97%849.62K | -75.32%1.26M | -15.26%499.88K |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | -63.90%82.65K | 19.45%281.75K | 2,832.70%293.27K | --889.49K | --414.65K | --228.97K | --235.88K | --10K | --0 | --0 |
| Interest paid (cash flow from financing activities) | --0 | -164.54%-61.73K | 22.36%-31.06K | -434.94%-203.95K | -268.82%-140.61K | --0 | ---23.33K | ---40K | 30.23%-38.13K | -282.67%-38.13K |
| Net other financing activities | ---12.36K | -40.15%-9.11K | 95.10%-1.73K | -1,464.71%-217.89K | -13,642.66%-176.19K | --0 | ---6.5K | -131.16%-35.2K | 97.82%-13.93K | 100.96%1.3K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 241.10%775.55K | -27.05%165.38K | -72.61%226.54K | 53.07%2.09M | 97.05%805.11K | -27.48%227.37K | 110.52%226.72K | 55.13%827.11K | -75.47%1.36M | -75.65%408.59K |
| Net cash flow | ||||||||||
| Beginning cash position | -91.74%11.79K | -30.48%48.45K | 721.33%452.74K | 293.64%55.12K | -46.20%34.43K | 568.58%142.61K | 1,190.42%69.69K | 293.64%55.12K | -473.93%-28.47K | -38.37%63.99K |
| Current changes in cash | 492.75%463.38K | -192.96%-64.68K | -1,118.52%-404.75K | 386.78%435.88K | 5,600.71%444.54K | -244.31%-117.98K | 399.81%69.58K | 71.32%39.74K | 1,377.36%89.54K | 106.50%7.8K |
| Effect of exchange rate changes | 13.55%11.13K | 738.17%28.02K | 101.82%457 | -542.68%-38.26K | -57.39%-26.23K | -22.64%9.8K | 499.88%3.34K | -2,147.59%-25.17K | 63.91%-5.95K | -35.90%-16.67K |
| End cash Position | 1,312.50%486.3K | -91.74%11.79K | -30.48%48.45K | 721.33%452.74K | 721.33%452.74K | -46.20%34.43K | 568.58%142.61K | 1,190.42%69.69K | 293.64%55.12K | 293.64%55.12K |
| Free cash from | -6.16%-365K | -35.87%-212.9K | 19.15%-632.61K | -9.96%-1.8M | -31.37%-515.42K | -20.77%-343.82K | 61.06%-156.69K | -40.69%-782.46K | 65.17%-1.64M | 58.93%-392.33K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.